MBB Public Markets I LLC Purchases 23,763 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

MBB Public Markets I LLC boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1,739.6% in the 2nd quarter, HoldingsChannel reports. The firm owned 25,129 shares of the medical equipment provider’s stock after buying an additional 23,763 shares during the period. MBB Public Markets I LLC’s holdings in Intuitive Surgical were worth $11,179,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Creekmur Asset Management LLC lifted its position in Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares in the last quarter. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical in the second quarter worth about $26,000. Able Wealth Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $28,000. Delos Wealth Advisors LLC lifted its position in shares of Intuitive Surgical by 380.0% during the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares in the last quarter. Finally, LRI Investments LLC acquired a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $30,000. 83.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have commented on ISRG. Truist Financial increased their price objective on Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a research report on Tuesday, July 16th. Robert W. Baird raised their price target on Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a report on Friday, July 19th. JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $475.00 to $495.00 and gave the stock an “overweight” rating in a report on Friday, July 19th. Redburn Atlantic upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their target price for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. Finally, Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a research report on Friday, July 19th. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $446.45.

Intuitive Surgical Stock Up 0.4 %

Shares of NASDAQ:ISRG opened at $486.33 on Friday. The firm has a market cap of $172.82 billion, a price-to-earnings ratio of 87.79, a PEG ratio of 5.39 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $496.18. The company’s fifty day simple moving average is $471.14 and its 200 day simple moving average is $427.11.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating the consensus estimate of $1.54 by $0.24. The firm had revenue of $2.01 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.18 EPS. Research analysts expect that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, insider Mark Brosius sold 2,115 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total value of $1,040,389.65. Following the completion of the sale, the insider now owns 295 shares of the company’s stock, valued at approximately $145,113.45. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, EVP Myriam Curet sold 2,818 shares of the firm’s stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total value of $1,291,010.34. Following the completion of the sale, the executive vice president now directly owns 298 shares of the company’s stock, valued at $136,522.74. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Mark Brosius sold 2,115 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total value of $1,040,389.65. Following the transaction, the insider now directly owns 295 shares in the company, valued at $145,113.45. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 53,120 shares of company stock worth $25,528,753. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.